Log In
Saturday 17th February 2018

US rescind approval for Avastin

21st November 2011

US drug regulators say Avastin is not effective enough to justify risks of taking it.

Click on available sources in right hand menu to see the original article.

Share this page


chelsey wayne

Wednesday 23rd November 2011 @ 8:31

Avastin is a cancer drug manufactured by Genentech, a part of Roche Pharmaceuticals. The Food and Drug Administration approval for Avastin was conditional. The Food and Drug Administration allowed it to be used only pending certain studies. Now that those studies have been finished, the approval has been taken away. Here is the proof: Approval pulled for Avastin breast cancer drug

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: US rescind approval for Avastin
Author: Martine Hamilton
Article Id: 20380
Date Added: 21st Nov 2011


BBC News

Recent Related Articles

Thousands spent to find chief executive who left after four months


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018